IDH-mutant gliomas
Clinical trials for IDH-mutant gliomas explained in plain language.
Never miss a new study
Get alerted when new IDH-mutant gliomas trials appear
Sign up with your email to follow new studies for IDH-mutant gliomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill aims to stall a common brain Tumor's growth
Disease control Not yet recruitingThis study tests whether the experimental drug safusidenib can slow or stop the growth of a type of slow-growing brain tumor called grade 2 glioma that has a specific genetic change (IDH1 mutation). Participants have had surgery but no other treatments like chemotherapy or radiat…
Matched conditions: IDH-MUTANT GLIOMAS
Phase 3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a nationwide charting of brain tumors reveal who is most affected?
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 350 people in Brazil diagnosed with IDH-mutant diffuse glioma, a type of brain tumor, from 2021 onward. Researchers will collect information on age, race, income, education, and other factors to build a detailed picture of who gets …
Matched conditions: IDH-MUTANT GLIOMAS
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC